Translational Research of Phase II study of FOLFIRI+Ramucirumab with early recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin / fluoropyrimidine (RAINCLOUD)
Not Applicable
Recruiting
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000028678
- Lead Sponsor
- MCSGO: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are regarded as inadequate for study enrollment by investigators 2) Patients who refuse to supply the samples
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma levels of VEGF-A,PlGF and VEGFR-1
- Secondary Outcome Measures
Name Time Method